Odyssey Therapeutics, Inc.ODTX

NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Price (close)
$19.93
Market cap
$957.8M
P/E
—
Revenue (FY)
—
Net income
—
Dividend yield
—
1-year total return
—
Net margin
—
Revenue growth
—
Debt / equity
—

What Odyssey Therapeutics, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year20242025

More on ODTX.

Figures from Odyssey Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.